Recent Bookmarks and Annotations
-
NCADI: Naltrexone And Alcoholism Treatment on 2009-12-09
-
-
At the currently recommended dose of 50 mg daily, hepatic toxicity is very unlikely. Continued alcohol use is more likely than naltrexone to cause liver damage. Before determining a patient's eligibility for naltrexone therapy, clinicians should be aware that alcohol alone may be responsible for pretreatment elevated liver function test (LFT) results. In some cases, simply stopping the consumption of alcohol will immediately lower LFT values appreciably.
-
-
At the currently recommended dose of 50 mg daily, hepatic toxicity is very unlikely. Continued alcohol use is more likely than naltrexone to cause liver damage. Before determining a patient's eligibility for naltrexone therapy, clinicians should be aware that alcohol alone may be responsible for pretreatment elevated liver function test (LFT) results. In some cases, simply stopping the consumption of alcohol will immediately lower LFT values appreciably.
-
- e currently recommended dose of 50 mg daily, hepatic toxicity is very unlikely. Continued alcohol use is more likely than naltrexone to cause liver damage. Before determining a patient's eligibility for naltrexone therapy, clinicians should be aware that alcohol alone may be responsible for pretreatment elevated liver function test (LFT) results. In some cases, simply stopping the consumption of alcohol will immediately lower LFT values appreciably. When there is a question, the Consensus Panel recommends repeating LFTs after 5 to 7 days of abstinence. (2) If the levels dramatically improve, then the patient may be a suitable candidate for naltrexone.
- Providers should perform LFTs prior to treatment initiation and periodically during treatment. The Consensus Panel recommends caution in using naltrexone with patients whose serum aminotransferases results are five times above normal. (1) Because total bilirubin reflects more severe and potentially chronic liver dysfunction, the Consensu
-
- terest and willingness to take naltrexone are important considerations.
- At the currently
-
At the currently recommended dose of 50 mg daily, hepatic toxicity is very unlikely. Continued alcohol use is more likely than naltrexone to cause liver damage. Before determining a patient's eligibility for naltrexone therapy, clinicians should be aware that alcohol alone may be responsible for pretreatment elevated liver function test (LFT) results. In some cases, simply stopping the consumption of alcohol will immediately lower LFT values appreciably
-
At the currently recommended dose of 50 mg daily, hepatic toxicity is very unlikely. Continued alcohol use is more likely than naltrexone to cause liver damage. Before determining a patient's eligibility for naltrexone therapy, clinicians should be aware that alcohol alone may be responsible for pretreatment elevated liver function test (LFT) results. In some cases, simply stopping the consumption of alcohol will immediately lower LFT values appreciably
-
At the currently recommended dose of 50 mg daily, hepatic toxicity is very unlikely. Continued alcohol use is more likely than naltrexone to cause liver damage. Before determining a patient's eligibility for naltrexone therapy, clinicians should be aware that alcohol alone may be responsible for pretreatment elevated liver function test (LFT) results. In some cases, simply stopping the consumption of alcohol will immediately lower LFT values appreciably
-
At the currently recommended dose of 50 mg daily, hepatic toxicity is very unlikely. Continued alcohol use is more likely than naltrexone to cause liver damage. Before determining a patient's eligibility for naltrexone therapy, clinicians should be aware that alcohol alone may be responsible for pretreatment elevated liver function test (LFT) results. In some cases, simply stopping the consumption of alcohol will immediately lower LFT values appreciably
-
At the currently recommended dose of 50 mg daily, hepatic toxicity is very unlikely. Continued alcohol use is more likely than naltrexone to cause liver damage. Before determining a patient's eligibility for naltrexone therapy, clinicians should be aware that alcohol alone may be responsible for pretreatment elevated liver function test (LFT) results. In some cases, simply stopping the consumption of alcohol will immediately lower LFT values appreciably
-
At the currently recommended dose of 50 mg daily, hepatic toxicity is very unlikely. Continued alcohol use is more likely than naltrexone to cause liver damage. Before determining a patient's eligibility for naltrexone therapy, clinicians should be aware that alcohol alone may be responsible for pretreatment elevated liver function test (LFT) results. In some cases, simply stopping the consumption of alcohol will immediately lower LFT values appreciably
-
At the currently recommended dose of 50 mg daily, hepatic toxicity is very unlikely. Continued alcohol use is more likely than naltrexone to cause liver damage. Before determining a patient's eligibility for naltrexone therapy, clinicians should be aware that alcohol alone may be responsible for pretreatment elevated liver function test (LFT) results. In some cases, simply stopping the consumption of alcohol will immediately lower LFT values appreciably.
-
At the currently recommended dose of 50 mg daily, hepatic toxicity is very unlikely. Continued alcohol use is more likely than naltrexone to cause liver damage. Before determining a patient's eligibility for naltrexone therapy, clinicians should be aware that alcohol alone may be responsible for pretreatment elevated liver function test (LFT) results. In some cases, simply stopping the consumption of alcohol will immediately lower LFT values appreciably.
-
How does Adderall work? - Yahoo! Answers on 2009-09-02
-
it causes the brain to release more of a chemical called norepenephrine (which is stored at the ends of nerves) and this causes a person's metabolic processes to speed up (including heart rate) which causes food to be converted into usable energy faster.
-
cause an increase in dopamine in between the neurons in your brain. dopamine is a neurotransmitter which means that it is a chemical necessary for different brain cells to communicate with each other. by increasing the amount of dopamine between neurons, it allows the brain cells to increase efficiency which causes a general sense of being energetic and usually makes it easier to pay attention, learn things, etc...
-
Study shows how ADHD drugs Adderall, Ritalin and Dexedrine work in brain on 2009-09-02
-
ADHD drugs fall into a class of medications known as stimulants. ADHD stimulants boost levels of two neurotransmitters, or chemical messengers in the brain, known as dopamine and norepinephrine.
-
Adderall Information from Drugs.com on 2009-09-02
-
Adderall is a central nervous system stimulant. It affects chemicals in the brain and nerves that contribute to hyperactivity and impulse control.
-
Adderall is used to treat narcolepsy and attention deficit hyperactivity disorder (ADHD).
-
Amphetamine - Wikipedia, the free encyclopedia on 2009-09-02
-
-
Amphetamine exerts its behavioral effects by modulating the behavior of several key neurotransmitters in the brain, including
dopamine,
serotonin, and
norepinephrine. However, the activity of amphetamine throughout the brain appears to be specific;
[16] certain receptors that respond to amphetamine in some regions of the brain tend not to do so in other regions. For instance,
dopamine D2 receptors in the
hippocampus, a region of the brain associated with forming new memories, appear to be unaffected by the presence of amphetamine.
[16]
-
-
neurotransmitters involved in various reward pathways of the brain appear to be the primary targets of amphetamine.
[17] One such neurotransmitter is
dopamine, a chemical messenger heavily active in the
mesolimbic and
mesocortical reward pathways. Not surprisingly, the anatomical components of these pathways—including the
striatum, the
nucleus accumbens, and the
ventral striatum—have been found to be primary sites of amphetamine action.
[18][19]
-
Adderall - Wikipedia, the free encyclopedia on 2009-09-02
-
Op-Ed Contributor - The Misguided Quest for Universal Coverage - NYTimes.com on 2009-04-10
-
AMERICA’S dysfunctional health care financing system needs to be reformed. But the goal should not be universal coverage. Reform should simply aim to make health insurance more affordable and portable.
-
Young and healthy people, especially, would be forced to overpay. So we would end up with more cost-shifting, and no savings.
-
-
This is another way of saying that universal coverage cannot be achieved using free-market methods — a point that many liberals correctly make
-
As Michael Cannon, a health policy analyst at the Cato Institute, has written, “There is no evidence that a dollar spent on universal coverage will save more lives than a dollar spent on clinics, or reducing medical errors, or nutrition, or fighting poverty, or even improving education.” And if universal coverage generally reduces the quality of care or retards medical innovation, it could end up being bad for everyone, including the poor.
-
Practice Problems on 2009-02-11
-
Orthodontic Topics | on 2009-02-10
-
The Orthodontic CYBERjournal: Sure Smile on 2009-02-10
-
We are also a society driven by multi-speed
and instant gratification.
-
demand for orthodontic care
is increasing
-
-
The number of patients seeking orthodontic care is expected
to double over the next decade from about two to four million.
-
The orthodontic industry needs cost-effective
care solutions that are patient-sensitive, quality-oriented and offer reduction
in treatment time so that the current practice is adequately prepared to manage
an increase in the patient load factor. Therefore a better understanding of
factors that retard the orthodontic care cycle need to be identified and solutions
found. Review of the delivery of orthodontic care suggests that the greatest
difficulty in further reducing the care cycle and care visits while achieving
quality care is caused by the aggregation of errors in the orthodontic care
process. Such errors result from a multiplicity of factors such as misdiagnosis
of the problem, miscommunication between the doctor and patient, and most importantly
misprescription and misplacement of the orthodontic appliance systems.
-
red
orthodontic care environment will require the practitioner to jump the seek
creative and innovative technology-based solutions with tools to decrease care
process errors. The confluence of the expectations of patients and doctors will
be the hallmark of the successful practice in the future, whose the mantra will
be patient-centered, excellence, error reduction, effectiveness, efficiency
and experience-based. Such a care environment will provide cost-effective, reliable,
and reproducible, on-time care solutions that eliminate error that plaque the
quality and management of a high volume practice.
-
Starting from this baseline, the
goal of Sure Smile is to minimize errors related to fixed appliance therapy
by augmenting the time-tested best practices with 3-D image capturing tools,
computer-based 3-D treatment planning software and automation technology to
fabricate precision archwires and precision bracket placement trays that result
in effectiveness and efficiency of orthodontic care. SureSmile offers unique
visual tools for patient communication and care monitoring.
-
• OraScanner™—The
OraScanner is a handheld scanning device that directly captures a three-dimensional
image of the dentition in vivo. The processed OraScan™ provides a
3-D image of the patient’s dentition that can be viewed and measured in
all planes of space to define the spatial position of the entire dentition.
Additionally, the OraScan can be very effectively used during patient visits
to explain treatment approaches and for patient education.
-
• SureSmile Software—The
SureSmile software allows the orthodontist to visualize and plan different
treatment scenarios through the manipulation of digital diagnostic set ups
and also design customized orthodontic appliances on a virtual workbench
in three-dimensional space. Different care modalities can be simulated in
real-time allowing the selection of an appropriate treatment plan and appliance
system. This approach eliminates the error-prone and time-consuming manual
planning processes associated with traditional approaches such as diagnostic
setups, VTOs and occlusograms.
Groups
Mary huynh havn't joined any group yet.
Home
